Sat. Jun 15th, 2024

“Specific therapies with few side effects should be available to cancer patients faster than previously possible – that is the goal of our company.”

PD dr Barbara Mayer and PD Dr. Ilona Funke, the founders of Spherotec GmbH

  • Identify promising active ingredients at an early stage
  • Recognizing undesirable effects early on
  • Optimizing the life cycle management of medicines
  • Use animal experiments in a more targeted and economical manner